Table 6.
Emergency calls for patients administered metadoxine by ES to be admitted or not admitted to the emergency department in 2-year periods (2018–2019, pre-COVID-19 period; 2020–2021, COVID-19 period) by age groups.
| Age Groups (Years) | Period | ED Group | NED Group |
|---|---|---|---|
| 11–17 | 2018–2019 | 43/47 (91.5%) | 24/26 (92.3%) |
| 2020–2021 | 28/29 (96.6%) | 13/14 (92.9%) | |
| 18–24 | 2018–2019 | 85/96 (88.5%) | 39/46 (84.8%) |
| 2020–2021 | 32/37 (86.5%) | 37/45 (82.2%) | |
| 25–44 | 2018–2019 | 166/213 (77.9%) | 104/150 (69.3%) |
| 2020–2021 | 62/86 (72.1%) | 64/83 (77.1%) | |
| 45–64 | 2018–2019 | 124/184 (67.4%) | 107/161 (66.5%) |
| 2020–2021 | 60/83 (72.3%) | 79/102 (77.5%) | |
| >65 | 2018–2019 | 24/33 (72.7%) | 22/29 (75.9%) |
| 2020–2021 | 10/16 (62.5%) | 11/21 (52.4%) |